Do’s and Don’ts” for intraarterial chemotherapy for retinoblastoma- What ophthalmologist and interventional radiologist need to know?
Intra-arterial chemotherapy (IAC) has emerged as the primary treatment option for retinoblastoma management. It enables the localized delivery of a higher concentration of chemotherapeutic agents (melphalan, carboplatin and topotecan) in the ophthalmic artery, enhancing tumour control and potentiall...
Saved in:
| Main Authors: | Pallav Bhatter, Rajsrinivas Parthasarathy, Vipul Gupta, Srinivas Rao Dusa, Ujjwal Aggarwal, Sima Das, Pallav Kumar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-06-01
|
| Series: | Indian Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/IJO.IJO_2912_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retinoblastoma Morphology after Local Chemotherapy
by: S. V. Saakyan, et al.
Published: (2021-10-01) -
Hidden Culprit: Middle Cerebral Artery Fenestration as an Overlooked Cause of Stroke in a 4 Year Old
by: Pallav Bhatter, et al.
Published: (2025-05-01) -
Retrograde Approach for Intra-arterial Chemotherapy Delivery in Retinoblastoma
by: Giancarlo Saal-Zapata, et al.
Published: (2021-06-01) -
Episcleral Iodine-125 radioactive plaque brachytherapy as a salvage treatment for retinoblastoma in the era of intraarterial chemotherapy
by: Ahmet Murat Sarıcı, et al.
Published: (2022-04-01) -
Veins of Deception: An Intriguing Case of Extradural Spinal AVF Mimicking Longitudinal Extensive Transverse Myelitis
by: Ujjwal Agarwal, et al.